Advinus Therapeutics, a research-based pharmaceutical development company promoted by the TATA Group, and SignalChem Pharmaceuticals, a British Columbia-based drug discovery company, have started working on 15 programs based on SignalChem’s proprietary Kinase platform for targeted therapies in oncology. Each program is being developed with corresponding diagnostics and tracers for patient ...
CYTOO SA, a company that specializes in cell-based assays, is pleased to announce the closing of a series C funding round of USD 10M (EUR 7M). New investors, Sham and Entrepreneurs Fund (EF), led the round. Existing investors AURIGA Partners and Jacques Lewiner, co-founder and president of the supervisory board ...
GenQual is pleased to announce initial closing of its first preferred equity round. Financial terms were not disclosed. This inaugural funding round allows GenQual to pursue proof-of-principle testing for its companion diagnostic approach for IL-6 mAb and other JAK/STAT inhibitors for autoimmune diseases and oncology indications. GenQual aims to prospectively ...
November 10th 2011
Categories:
Biotech,
Biotech Services,
Biotechnology,
DNA,
Genetics,
Genome,
Medicine,
Microarrays,
Pharmaceuticals,
RNA,
Science
No Comments
St. Clair Shores, Michigan and Cambridge, Massachusetts – Michigan Institute of Urology, P. C. (MIU) and Cellay, Inc. today announced that MIU will exclusively perform a clinical trial for prostate cancer using Cellay's Same Day OligoFISH® probe panel. Data from this trial will be included in Cellay's premarket approval (PMA) ...
April 29th 2011
Categories:
Biochemicals,
Biopharmaceutical,
Biotech,
Biotech Products,
Biotech Services,
Biotech Solutions,
Biotechnology,
Healthcare,
Medicine,
Pharmaceuticals,
Science
No Comments
Investor Stem Cell (http://www.investorstemcell.com) is dedicated to bringing investors and stakeholders together in thoughtful discussion to educate and publicize the incredible medical advancements taking place in the regenerative medicine sector. Scientists are using stem cells both (hESC) and (iPSC) in hopes of easing the suffering of hundreds of millions of people ...
MicroTissues, Inc. announced today the launch of its 3D Petri Dish™ line of products. The 3D Petri Dish™ is a new tool for the world wide industry of life sciences research and drug discovery. Invented at Brown University, the 3D Petri Dish™ grows living human cells in three dimensions (3D) ...
MicroTissues, Inc. announced today that its 3D Petri Dish™ is targeted towards helping to reduce the numbers of animals used in research. The 3D Petri Dish™ is a new tool for the world wide industry of life sciences research and drug discovery that grows living cells in three dimensions (3D). These ...
MicroTissues, Inc. announced today that its 3D Petri Dish™ was used in one of Time magazine’s medical breakthroughs of 2010. Researchers at Brown University and Women and Infants Hospital used the 3D Petri Dish™ to invent the first artificial human ovary, a discovery important for fertility research and a possible infertility ...
Molplex and Enamine today announced a new partnership to offer the Enamine screening collection of 1.8 million stock chemicals through the Molplex online drug design and assay-ready chemical supply services. The agreement is a major step towards eliminating the high start-up costs ofdrug discovery, bringing sophisticated drug design, compound management and assay-ready chemistry to ...
January 24th 2011
Categories:
Biochemicals,
Biomedical Engineering,
Biopharmaceutical,
Biotech,
Biotech Products,
Biotech Services,
Biotech Solutions,
Biotechnology,
DNA,
Gene,
Genome,
Healthcare,
Pharmaceuticals,
Science
No Comments
Researchers task force, led by faculties of T-Protocol, registered Genom Project as controlled genom project in the hosted database of NCBI, a publication matter authority and function assigned organization under oversee of Department of Health & Human Services, reached once to share the exegetical impression officially pre-published concerning the understanding ...
January 13th 2011
Categories:
Biochemicals,
Biomedical Engineering,
Biopharmaceutical,
Biotech,
Biotech Products,
Biotech Services,
Biotech Solutions,
Biotechnology,
DNA,
Gene,
Genome,
Healthcare,
Pharmaceuticals,
Science
No Comments
Division of Gene Medicine & Stem Cell Application, School of Medical Science, complete the research and established completely new protocol totally recovering natural bio mechanism of hair regrowth.
The researchers, led by Lord. Prof. Dr. Daichent Otto Rie, specified protein and genom to affect internal bio mechanism to generate hair and control ...
An innovative new online “drug discovery on demand” platform has been launched by Molplex, a company specializing in products and services for the life sciences. Designed to help drug discovery groups working anywhere in the world, it aimsto eliminate the high start-up costs and minimize the financial risks traditionally associated ...
A recent report on the biopharmaceutical sector presence, employment, economic output and research and development activity in the European States highlights Turkey’s long-term prospects for growth. The report notes that the industry is creating a positive ripple across the region’s economy, improving the quality of life for its citizens and ...
July 10th 2010
Categories:
Biochemicals,
Biopharmaceutical,
Biotech,
Biotech Products,
Biotech Services,
Biotech Solutions,
Biotechnology,
Healthcare,
Medicine,
Pharmaceuticals,
Science
No Comments
Cryo-Cell International, Inc. a global leader in stem cell innovation, resolves to help women inspire and empower each other to take charge of their health in the New Year, and to spark conversations about the promise of stem cells. The company will be accepting video entries for its “Resolution Revolution” ...
July 10th 2010
Categories:
Biochemicals,
Biopharmaceutical,
Biotech,
Biotech Products,
Biotech Services,
Biotech Solutions,
Biotechnology,
Healthcare,
Medicine,
Pharmaceuticals,
Science
No Comments
For an expectant mother, there are a million details to worry about and a lot of important decisions to be made.
One of those decisions to be made is whether to bank your baby's umbilical cord blood. Cord blood is valuable because it's full of stem cells scientists and doctors can use ...
July 10th 2010
Categories:
Biochemicals,
Biopharmaceutical,
Biotech,
Biotech Products,
Biotech Services,
Biotech Solutions,
Biotechnology,
Healthcare,
Medicine,
Pharmaceuticals,
Science
No Comments
Dr. Joshua Hare believes medicine is close to a goal long thought to be impossible: healing the human heart.
The way to get there? Stem cells.
"These could be as big as antibiotics were in the last century," said Hare, who leads the University of Miami 's new Stem Cell Institute. "Stem ...
July 10th 2010
Categories:
Biochemicals,
Biopharmaceutical,
Biotech,
Biotech Products,
Biotech Services,
Biotech Solutions,
Biotechnology,
Healthcare,
Medicine,
Pharmaceuticals,
Science
No Comments
Researchers from Italy have reported that the injection of umbilical cord blood directly into the pelvic bones of patients with leukemia appears promising. These results were recently published in an early online publication of the Lancet Oncology on August 9, 2008.
Transplantation of bone marrow, peripheral blood stem cells, and umbilical cord blood is ...
July 10th 2010
Categories:
Biochemicals,
Biopharmaceutical,
Biotech,
Biotech Products,
Biotech Services,
Biotech Solutions,
Biotechnology,
Healthcare,
Medicine,
Pharmaceuticals,
Science
No Comments
Women in the city will soon have the option of banking their menstrual blood so that menstrual blood stem cells can be used for treatment of serious disorders through stem cell therapy.
In six months, Life Cell International, in technology partnership with Cryo-Cell International, will set up the facility, which will be ...
On August 23-25, 2010, industry scientists, CEOs, and academics will convene at Philadelphia’s Four Seasons Hotel for the “Ubiquitin Drug Discovery and Diagnostics Conference” to discuss the Next Big Thing in drug discovery research—the ubiquitin pathway. Advances in oncology, infectious diseases, neurodegeneration, inflammation, diabetes, and muscle wasting will be covered.
A ...
May 13th 2010
Categories:
Biochemicals,
Biopharmaceutical,
Biotech,
Biotech Products,
Biotech Services,
Biotech Solutions,
Biotechnology,
Healthcare,
Medicine,
Pharmaceuticals,
Science
No Comments
Cryo-Cell International, Inc. today announced results of a study published [this month] in the cover article of Stem Cells and Developmentshowing that stem cells found in menstrual blood may one day be a potential source for stem cell therapies in stroke and other central nervous system disorders. Menstrual stem cells, known as ...
